Last reviewed: June 21, 2026 Last updated: June 21, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Your pre-sleep habits also matter
Liver fat reduction and MASLD improvement The liver data from retatrutide trials may end up being more consequential than the weight loss data for public health
What standard travel insurance covers Emergency medical treatment if you have an adverse reaction
GlpBio Products Cited In Reputable Papers Description of Semaglutide TFA Semaglutide TFA, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes
It acts on receptors in the hypothalamus and other brain regions involved in appetite regulation, decreasing hunger signals and food cravings